For first-degree relatives of patients with Crohn disease, increased antibody response is associated with subsequent risk for CD.
The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid limited options. The FDA has granted orphan drug designation (ODD) to ARB1002, ...
This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback